Results
1 -
10 of
28Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice, Psychopharmacology The ??4??2 agonist SIB 1765F, but not the ??7 agonist AR-R 17779, cross-sensitises to the psychostimulant effects of nicotine, Psychopharmacology ABT-089: An Orally Effective Cholinergic Channel Modulator (ChCM) with Cognitive Enhancement and Neuroprotective Action, Alzheimer Disease Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes, Neurochemical Research Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement, Psychopharmacology ABT-418: A Novel Cholinergic Channel Activator (ChCA) for the Potential Treatment of Alzheimer?s Disease, Alzheimer Disease ABT-418: discriminative stimulus properties and effect on ventral tegmental cell activity, Psychopharmacology Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist, Psychopharmacology ABT ? 418, a Novel Nicotinic Agonist, International Symposium on Nicotine: The Effects of Nicotine on Biological Systems II Non-stimulant treatments for ADHD, European Child & Adolescent Psychiatry